Roche receives U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus Read more
Ferring Pharmaceuticals and Gubra announce collaboration within inflammatory bowel disease (IBD) Read more
Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review Read more
Health Canada approves KERENDIA (finerenone) as an adjunct to standard of care therapy in adults with chronic kidney disease (CKD) and type 2 diabetes (T2D) Read more
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development Read more
WHO Expands Recommendation for Veklury (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline Read more
Mallinckrodt Receives FDA Approval for Terlivaz (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) Read more